Journal Information
Vol. 36. Issue 10.
Pages 779-780 (October 2017)
Share
Share
Download PDF
More article options
Vol. 36. Issue 10.
Pages 779-780 (October 2017)
Image in Cardiology
Open Access
Pulmonary arteriovenous malformation closure in a preterm newborn
Encerramento de fístula arteriovenosa pulmonar em recém-nascido pré-termo
Visits
4222
Petra Loureiroa,
Corresponding author
petra.loureiro@gmail.com

Corresponding author.
, Sérgio Laranjoa, Maria João Lageb, Conceição Trigoa, Fátima F. Pintoa, José Diogo F. Martinsa
a Cardiologia Pediátrica, Hospital de Santa Marta, Centro Hospitalar Lisboa Central-EPE, Lisboa, Portugal
b Unidade de Cuidados Intensivos Neonatal, Hospital Dona Estefânia, Centro Hospitalar Lisboa Central-EPE, Lisboa, Portugal
This item has received

Under a Creative Commons license
Article information
Full Text
Download PDF
Statistics
Figures (2)
Full Text

A 23-day-old preterm baby (1900 g) presenting with severe hypoxemia secondary to a large pulmonary arteriovenous malformation (PAVM), diagnosed by thoracic computed tomography (CT), was referred to our department.

He was born at 32 weeks of gestation weighing 1945 g and, after birth, presented with severe hypoxemia (peripheral oxygen saturation [SpO2] 65%). The cardiac assessment was unremarkable. The initial diagnosis was congenital pneumonia with persistent pulmonary hypertension of the newborn and he was treated with antibiotics and ventilated with nitric oxide. In the absence of clinical improvement a thoracic CT scan was performed, which raised suspicion of a PAVM (Figure 1).

Figure 1.

(A and B) Thoracic computed tomography scan showing a pulmonary arteriovenous malformation of the right lower lobe.

(0.2MB).

Cardiac catheterization performed under general anesthesia demonstrated a large PAVM in the right lower lobe with two afferent arteries, one 3.1 mm and the other 6 mm in diameter. The first was occluded with a 4 mm Amplatzer® Duct Occluder II (St. Jude Medical, St. Paul, MN) and the other with a 7 mm Amplatzer® Vascular Plug (St. Jude Medical, St. Paul, MN), both implanted through a 4 F delivery sheath (Figure 2). The patient's SpO2 immediately increased to 98% and he was discharged home 20 days after the procedure. One year later, he remains asymptomatic.

Figure 2.

(A) Selective angiography of the right pulmonary artery showing a large pulmonary arteriovenous malformation with two afferent vessels; (B) successful closure of the 3.1 mm feeding artery with a 4 mm Amplatzer® Duct Occluder II and of the 6 mm feeding artery with a 7 mm Amplatzer® Vascular Plug (C and D).

(0.29MB).

This report emphasizes that percutaneous occlusion of PAVM should be the primary therapeutic option at any age. To our knowledge, this is the first such report in the literature in a low birth weight preterm newborn. Amplatzer® devices were the appropriate choice as they fit in a small sheath and are repositionable and suitable for large vessels, ensuring a high occlusion rate.

Ethical disclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that no patient data appear in this article.

Right to privacy and informed consent

The authors declare that no patient data appear in this article.

Conflicts of interest

The authors have no conflicts of interest to declare.

Copyright © 2017. Sociedade Portuguesa de Cardiologia
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.